Metal–organic framework-based therapeutic strategies for hepatocellular carcinoma: current advances and future perspectives
This review highlights the recent progress in MOF-based nanomedicine for liver cancer treatment specifically HCC, emphasizing targeting strategies that enhance the selective accumulation of MOF nanocarriers in liver tumors, including passive targeting via the enhanced permeability and retention (EPR) effect and active...